GHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.View
The International Vaccine Institute (IVI) is the world's only international organization devoted exclusively to developing and introducing new and improved vaccines for global public health. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization.Learn More
Why we're needed
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.Learn More
GHTC Welcomes Positive Opinion from European Medicines Agency on First Long-acting Vaginal Ring to Protect Women Against HIV
Today, the European Medicines Agency adopted a positive opinion under Article 58 for use of the monthly dapivirine ring by cisgender women ages 18 and older in developing countries—a move that we at the GHTC applaud as a major milestone for women’s HIV prevention efforts.Learn more
GHTC joined a scientific community letter to Congressional leaders urging Congress do do everything possible to maintain the United States' membership and funding for the World Health Organization (WHO).PDF
With support from the US Agency for International Development’s (USAID) global health Grand Challenges for Development program led by the Center for Innovation and Impact, global innovators have been designing and scaling up affordable solutions to the world’s most significant global health challenges. With the toll of COVID-19 now intensifying in low- and middle-income countries, many of these innovations are turning their attention to this new challenge.
Research Roundup: Phase 3 vaccine trials, a rapid saliva-based COVID-19 test, and diversity in clinical trials
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.